Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig

Clinical trial NCT03730129 · COMPLETED

Trial details

NCT number: NCT03730129
Sponsor: Rochester General Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Secondary Immune Deficiency Disorder

Start date: 2018-11-05
Primary completion: 2020-07-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.